Cost-Effectiveness Analysis Of Linezolid Versus Vancomycin In The Treatment Of Nosocomial Pneumonia Caused By Methicillin Resistant Staphylococcus Aureus (Mrsa) Based On A Phase 4 Clinical Trial

May 1, 2013, 00:00 AM
10.1016/j.jval.2013.03.422
https://www.valueinhealthjournal.com/article/S1098-3015(13)00493-2/fulltext
Section Title : Infection
Section Order : 1473
First Page : A91
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00493-2&doi=10.1016/j.jval.2013.03.422
HEOR Topics :
Tags :
Regions :